SolarBank Corp. (SUUN) Taps Data Center Veteran Jonathan Martone to Guide Data Center Market Expansion

Thumzup Media Corp. (TZUP) Continues to Boost Client Numbers, Using AI to Speed Innovation

ESGold Corp. (ESAUF) Advances Subsurface Imaging to Expand Montauban Project Potential

Torr Metals Inc. (TMET): Strategic Exploration in Established Mining Districts

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Sinovac Biotech, Ltd. (AMEX: SVA)

November 3, 2008 at 5:34am

Sinovac Biotech, Ltd. (AMEX: SVA) is one of the emerging biotech companies in China. Sinovac (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and “SARS”. While the young company has gained national recognition for its Hepatitis A vaccine, they are the only company in the world to have been granted permission to begin clinical trials for a vaccine to prevent SARS. For further information, visit the company website at: www.Sinovac.com.

Archives

Select A Month

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.